Resveratrol is a kind of polyphenolic compound that widely exists in plants and has extensive physiological pharmacological function and is very useful for human health. For the mechanism of action and function of RV, people are doing a variety of groundbreaking researches. Results show that the molecular mechanism of RV is embodied in aspects such as oxidative stress and diseases of neuropathy, anti-oxygenation and pro-oxidant effect and RV target molecule, etc. This article mainly summarized the mechanism of action of resveratrol in these aspects.
KeywordsResveratrolOxidative StressAntioxidant EffectPro-Oxidant EffectTarget Molecule of Resveratrol
Kimura, Y., Okuda, H. and Arichi, S. (1985) Effects of Stibenes on Arachidonate Metabolism in Leukocytes. Biochimica et Biophysica Acta, 834, 275-278.
Walle, T., Hsieh, F., DeLegge, M.H., Oatis Jr., J.E. and Walle, U.K. (2004) High Absorption But Very Low Bioavailability of Oral Resveratrol in Humans. Drug Metabolism and Disposition, 32, 1377-1382. http://dx.doi.org/10.1124/dmd.104.000885
Walle, T. (2011) Bioavailability of Resveratrol. Annals of the New York Academy of Sciences, 1215, 9-15. http://dx.doi.org/10.1111/j.1749-6632.2010.05842.x
Forman, H.J. (2010) Reactive Oxygen Species and Alpha, Beta-Unsaturated Aldehydes as Second Messengers in Signal Transduction. Annals of the New York Academy of Sciences, 1203, 35-44. http://dx.doi.org/10.1111/j.1749-6632.2010.05551.x
Granzotto, A. and Zatta, P. (2014) Resveratrol and Alzheimer’s Disease: Message in a Bottle on Red Wine and Cognition. Frontiers in Aging Neuroscience, 6, 95. http://dx.doi.org/10.3389/fnagi.2014.00095
La Spada, A.R. (2012) Finding a Sirtuin Truth in Huntington’s Disease. Nature Medicine, 18, 24-26. http://dx.doi.org/10.1038/nm.2624
Blesa, J., Phani, S., Jackson-Lewis, V., et al. (2012) Classic and New Animal Models of Parkinson’s Disease. Journal of Biomedicine and Biotechnology, 2012, Article ID: 845618. http://dx.doi.org/10.1155/2012/845618
Herskovits, A.Z. and Guarente, L. (2013) Sirtuin Deacetylases in Neurodegenerative Diseases of Aging. Cell Research, 23, 746-758. http://dx.doi.org/10.1038/cr.2013.70
Gutteridge, J.M. (1986) Iron Promoters of the Fenton Reaction and Lipid Peroxidation Can Be Released from Haemoglobin by Peroxides. FEBS Letters, 201, 291-295. http://dx.doi.org/10.1016/0014-5793(86)80626-3
Tatton, W.G., Chalmers-Redman, R., Brown, D., et al. (2003) Apoptosis in Parkinson’s Disease: Signals for Neuronal Degradation. Annals of Neurology, 53, S61-S72.
Seet, R.C., Lee, C.Y., Lim, E.C., Tan, J.J.H., Quek, A.M.L., Chong, W.-L., et al. (2010) Oxidative Damage in Parkinson Disease: Measurement Using Accurate Biomarkers. Free Radical Biology & Medicine, 48, 560-566. http://dx.doi.org/10.1016/j.freeradbiomed.2009.11.026
Cavallaro, A., Ainis, T., Bottari, C. and Fimiani, V. (2003) Effect of Resveratrol on Some Activities of Isolated and in Whole Blood Human Neutrophils. Physiological Research, 52, 555-562.
Iuqa, C., Alvarez-Idaboy, J.R. and Russo, N. (2012) Antioxidant Activity of Trans-Resveratrol toward Hydroxyl and Hydroperoxyl Radicals: A Quantum Chemical and Computational Kinetics Study. The Journal of Organic Chemistry, 77, 3868-3877. http://dx.doi.org/10.1021/jo3002134
Stivala, L.A., Savio, M., Carafoli, F., Perucca, P., Bianchi, L., Maga, G., et al. (2001) Specific Structural Determinants Are Responsible for the Antioxidant Activity and the Cell Cycle Effects of Resveratrol. The Journal of Biological Chemistry, 276, 22586-22594. http://dx.doi.org/10.1074/jbc.M101846200
Selvarai, S., Mohan, A., Narayanan, S., Sethuraman, S. and Krishnan, U.M. (2013) Dose-Dependent Interaction of Trans-Resveratrol with Biomembranes: Effects on Antioxidant Property. Journal of Medicinal Chemistry, 56, 970-981. http://dx.doi.org/10.1021/jm3014579
Tellone, E., De Rosa, M.C., Pirolli, D., Russo, A., Giardina, B., Galtieri, A. and Ficarra, S. (2014) Molecular Interactions of Hemoglobin with Resveratrol: Potential Protective Antioxidant Role and Metabolic Adaptations of the Erythrocyte. Biological Chemistry, 395, 347-354. http://dx.doi.org/10.1515/hsz-2013-0257
Galtieri, A., Tellone, E., Ficarra, S., Russo, A., Bellocco, E., Barreca, D., et al. (2010) Resveratrol Treatment Induces Redox Stress in Red Blood Cells: A Possible Role of Caspase 3 in Metabolism and Anion Transport. Biological Chemistry, 391, 1057-1065. http://dx.doi.org/10.1515/bc.2010.100
Pervaiz, S. (2003) Resveratrol: From Grapevines to Mammalian Biology. The FASEB Journal, 17, 1975-1985. http://dx.doi.org/10.1096/fj.03-0168rev
de la Lastra, C.A. and Villegas, I. (2007) Resveratrol as an Antioxidant and Pro-Oxidant Agent: Mechanisms and Clinical Implications. Biochemical Society Transactions, 35, 1156-1160. http://dx.doi.org/10.1042/BST0351156
Tsai, S.K., Hung, L.M., Fu, Y.T., Cheng, H., Nien, M.-W., Liu, H.-Y., Zhang, F.B.-Y. and Huang, S.-S. (2007) Resveratrol Neuroprotective Effects during Focal Cerebral Ischemia Injury via Nitric Oxide Mechanism in Rats. Journal of Vascular Surgery, 46, 346-353. http://dx.doi.org/10.1016/j.jvs.2007.04.044
Ahmad, A., Syed, F.A., Singh, S. and Hadi, S.M. (2005) Prooxidant Activity of Resveratrol in the Presence of Copper Ions: Mutagenicity in Plasmid DNA. Toxicology Letters, 159, 1-12. http://dx.doi.org/10.1016/j.toxlet.2005.04.001
Muqbil, I., Beck, F.W., Bao, B., Sarkar, F.H., Mohammad, R.M., Hadi, S.M. and Azmi, A.S. (2012) Old Wine in a New Bottle: The Warburg Effect and Anticancer Mechanisms of Resveratrol. Current Pharmaceutical Design, 18, 1645-1654. http://dx.doi.org/10.2174/138161212799958567
Kundu, J.K. and Surh, Y.J. (2008) Cancer Chemopreventive and Therapeutic Potential of Resveratrol: Mechanistic Perspectives. Cancer Letters, 269, 243-261. http://dx.doi.org/10.1016/j.canlet.2008.03.057
Fan, E., Jiang, S., Zhang, L. and Bai, Y. (2008) Molecular Mechanism of Apoptosis Induction by Resveratrol, a Natural Cancer Chemopreventive Agent. International Journal for Vitamin and Nutrition Research, 78, 3-8. http://dx.doi.org/10.1024/0300-9831.78.1.3
Herskovits, A.Z. and Guarente, L. (2013) Sirtuin Deacetylases in Neurodegenerative Diseases of Aging. Cell Research, 23, 746-758. http://dx.doi.org/10.1038/cr.2013.70
Simao, F., Matte, A., Pagnussat, A.S., Netto, C.A. and Salbego, C.G. (2012) Resveratrol Prevents CA1 Neurons against Ischemic Injury by Parallel Modulation of both GSK-3β and CREB through PI3-K/Akt Pathways. European Journal of Neuroscience, 36, 2899-2905. http://dx.doi.org/10.1111/j.1460-9568.2012.08229.x
Kennedy, D.O., Wightman, E.L., Reay, J.L., Lietz, G., Okello, E.J., Wilde, A. and Haskell, C.F. (2010) Effects of Resveratrol on Cerebral Blood Flow Variables and Cognitive Performance in Humans: A Double-Blind, Placebo-Controlled, Crossover Investigation. The American Journal of Clinical Nutrition, 91, 1590-1597. http://dx.doi.org/10.3945/ajcn.2009.28641
Sahin, E., Colla, S., Liesa, M., Moslehi, J., Müller, F.L., Guo, M., et al. (2011) Telomere Dysfunction Induces Metabolic and Mitochondrial Compromise. Nature, 470, 359-365. http://dx.doi.org/10.1038/nature09787
Scarpulla, R.C. (2011) Metabolic Control of Mitochondrial Biogenesis through the PGC-1 Family Regulatory Network. Biochimica et Biophysica Acta, 1813, 1269-1278. http://dx.doi.org/10.1016/j.bbamcr.2010.09.019
Kairisalo, M., Bonomo, A., Hyrskyluoto, A., Mudò, G., Belluardo, N., Korhonen, L. and Lindholm, D. (2011) Resveratrol Reduces Oxidative Stress and Cell Death and Increases Mitochondrial Antioxidants and XIAP in PC6.3-Cells. Neuroscience Letters, 488, 263-266. http://dx.doi.org/10.1016/j.neulet.2010.11.042
Jin, F., Wu, Q., Lu, Y.F., Gong, Q.-H. and Shi, J.-S. (2008) Neuroprotective Effect of Resveratrol on 6-OHDA-Induced Parkinson’s Disease in Rats. European Journal of Pharmacology, 600, 78-82. http://dx.doi.org/10.1016/j.ejphar.2008.10.005
Zhang, F., Shi, J.S., Zhou, H., Wilson, B., Hong, J.-S. and Gao, H.-M. (2010) Resveratrol Protects Dopamine Neurons against Lipopolysaccharide-Induced Neurotoxicity through Its Anti-Inflammatory Actions. Molecular Pharmacology, 78, 466-477. http://dx.doi.org/10.1124/mol.110.064535